Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Vaccinations

Vaccinations

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Microbial Legacy: Mycobacterium vaccae ATCC 15483<sup>T</sup> intergenerationally diversifies the microbiome and enhances stress resilience in male mice.

Molecular psychiatry·2026

Same author

A novel soil-derived Mycolicibacterium decreases anxiety-like defensive behavioral responses in association with decreases in biomarkers of neuroinflammation and hippocampal microglial priming in adult male rats.

Brain, behavior, and immunity·2026

Same author

A Gut Signature of Microbiome, Bile Acid, and Quorum-Sensing Profiles Is Associated with <i>Helicobacter pylori</i> Infection and Disease Progression.

Microorganisms·2026

Same author

The role of gut microbiome in the pathophysiology of PTSD, depression, and anxiety disorders.

Gut microbes reports·2026

Same author

Whole-blood transcriptomic response to whole-body hyperthermia in participants with major depressive disorder.

Brain, behavior, & immunity - health·2026

Same author

Electrophysiological effects of psilocybin co-administered with midazolam.

Translational psychiatry·2026

Search research articles

Related Experiment Video

Updated: May 23, 2026

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Can we vaccinate against depression?

Graham A W Rook¹, Charles L Raison, Christopher A Lowry

¹Centre for Clinical Microbiology, Department of Infection, University College London (UCL), London NW3 2PF, UK.

Drug Discovery Today

|April 18, 2012

Summary

This summary is machine-generated.

Major depression is linked to inflammation. Strategies like immunoregulation-inducing vaccines or gut microbiota modulation, already used for inflammatory conditions, may offer new depression treatments.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Related Experiment Videos

Last Updated: May 23, 2026

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Area of Science:

Immunology
Neuroscience
Microbiome research

Background:

Major depression frequently co-occurs with autoimmune and inflammatory diseases.
Elevated proinflammatory cytokines and inflammation markers are common in depression, even without other immune diagnoses.
This suggests a potential role for immune system dysregulation in depression.

Purpose of the Study:

To explore the potential of immunoregulation strategies for preventing or treating depression.
To review existing data supporting the efficacy of these approaches in depression.
To advocate for clinical vaccination trials in depression.

Main Methods:

Review of existing scientific literature and clinical trial data.
Analysis of the link between inflammation, immune system, and depression.
Exploration of therapeutic strategies targeting immunoregulation and gut microbiota.

Main Results:

Evidence suggests that targeting inflammation and immune pathways may be effective for depression.
Immunoregulation-inducing vaccines and gut microbiota manipulation are promising therapeutic avenues.
These strategies are already in clinical trials for other chronic inflammatory disorders.

Conclusions:

Vaccines and gut microbiota modulation represent a novel and potentially effective approach to treating depression.
Further clinical trials are warranted to confirm the efficacy of these immunomodulatory strategies in major depression.